Society of Cardiovascular Computed Tomography (SCCT)

The Society of Cardiovascular Computed Tomography (SCCT) focuses on the advancement and expansion of cardiac CT. The society serves a membership split about evenly between radiologists and cardiologists. SCCT hosts educational events, advocates for CCTA for reimbursement and helps set guidelines for cardiac imaging. The news, videos and content on this page are created by our Innovate Healthcare editorial team and focus on the clinical, operational and financial aspects of cardiac CT.

Ron Blankstein, MD, FACC, FASNC, MSCCT, FASPC, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women’s Hospital, and a professor of medicine and radiology, Harvard Medical School, explains a few of the recent advancements in cardiac MRI, nuclear imaging and computed tomography.

Exploring major breakthroughs in cardiac imaging

Ron Blankstein, MD, director of cardiac computed tomography for Brigham and Women’s Hospital, details recent developments in cardiac MRI, nuclear imaging and CT.

CMS may double Medicare payments for cardiac CT

The agency is gathering feedback on a proposal to double the amount hospitals are paid for coronary computed tomography angiography, with the comment period ending Sept. 9.

HeartFlow introduced its next generation artificial intelligence (AI) Plaque Analysis with an interactive experience at SCCT 2024. It shows a 3D plaque model and analysis by territory across calcified, non-calcified and low-attenuation plaques. This includes viewing cross-sectional, color-coded images of each plaque type where it was quantified along the vessel. #SCCT #SCCT24 #SCCT2024

Updated HeartFlow technology offers interactive features, full integration with FFR-CT 

HeartFlow is using SCCT 2024 to introduce the world to its updated Plaque Analysis platform. “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment," Chief Medical Officer Campbell Rogers, MD, explained.

SCCT aims to provide common language for CCTA use with updated guidance

The Society of Cardiovascular Computed Tomography has developed a new expert consensus document designed to get physicians on the same page when discussing this growing technology. 

HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.

AI-based CAD assessments as accurate as FFR, new 10-year study confirms

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Joseph Swicklik, RT, Mayo Clinic, demonstrates how to use magic to calm pediatric patients during imaging exams.

Using 'magic' to calm pediatric patients during imaging exams

Joseph Swicklik, RT(R)(CT), Mayo Clinic, says magic tricks can help calm pediatric patients to overcome anxiety and make medical imaging exams run much smoother.

Video of Renee Bullock-Palmer, MD, FSCCT, director, Women’s Heart Center, and director, non-invasive cardiac imaging, at the Deborah Heart and Lung Center in Browns Mills, New Jersey, explaining the latest guidelines that support use of CT angiography at SCCT 2023. #YesCCT #CCTA #CTA #SCCT #SCCT23 #SCCT2023

What new data, expert guidelines tell us about the future of cardiac CT

Renee Bullock-Palmer, MD, details the latest guidelines that support the continued use of CT angiography.

Himanshu Gupta, MD, explains use of FFR-CT in daily practice at Valley Health System, New Jersey at SCCT 2023. #FFRCT #Heartflow #SCCT #SCCT23 #SCCT2023

The benefits of implementing FFR-CT in clinical practice

Himanshu Gupta, MD, says the implementation of FFR-CT at his facility has provided significant value. He and his colleagues are even working to explore additional ways the technology can help them improve patient care. 

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.